交易 Ocugen, Inc. - OCGN CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.05 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Ocugen Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 1, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.43 | 0.43 |
May 31, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.44 | 0.43 |
May 30, 2023 | 0.43 | -0.02 | -4.44% | 0.45 | 0.45 | 0.43 |
May 26, 2023 | 0.44 | 0.01 | 2.33% | 0.43 | 0.44 | 0.42 |
May 25, 2023 | 0.43 | -0.04 | -8.51% | 0.47 | 0.47 | 0.43 |
May 24, 2023 | 0.45 | -0.08 | -15.09% | 0.53 | 0.53 | 0.43 |
May 23, 2023 | 0.69 | -0.01 | -1.43% | 0.70 | 0.75 | 0.69 |
May 22, 2023 | 0.69 | 0.05 | 7.81% | 0.64 | 0.71 | 0.63 |
May 19, 2023 | 0.65 | 0.01 | 1.56% | 0.64 | 0.65 | 0.63 |
May 18, 2023 | 0.63 | -0.04 | -5.97% | 0.67 | 0.67 | 0.61 |
May 17, 2023 | 0.67 | 0.00 | 0.00% | 0.67 | 0.67 | 0.65 |
May 16, 2023 | 0.67 | -0.01 | -1.47% | 0.68 | 0.71 | 0.66 |
May 15, 2023 | 0.71 | 0.06 | 9.23% | 0.65 | 0.72 | 0.65 |
May 12, 2023 | 0.65 | -0.04 | -5.80% | 0.69 | 0.69 | 0.64 |
May 11, 2023 | 0.68 | -0.05 | -6.85% | 0.73 | 0.73 | 0.67 |
May 10, 2023 | 0.72 | 0.01 | 1.41% | 0.71 | 0.74 | 0.70 |
May 9, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.71 | 0.67 |
May 8, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.72 | 0.68 |
May 5, 2023 | 0.67 | -0.02 | -2.90% | 0.69 | 0.69 | 0.66 |
May 4, 2023 | 0.67 | -0.01 | -1.47% | 0.68 | 0.69 | 0.65 |
Ocugen, Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Monday, June 5, 2023 | ||
时间(协调世界时) (UTC) 20:30 | 国家/地区 US
| 事件 Ocugen Inc at Biotechnology Industry Organization (BIO) International Convention Ocugen Inc at Biotechnology Industry Organization (BIO) International ConventionForecast -Previous - |
Wednesday, June 7, 2023 | ||
时间(协调世界时) (UTC) 12:00 | 国家/地区 US
| 事件 Ocugen Inc Annual Shareholders Meeting Ocugen Inc Annual Shareholders MeetingForecast -Previous - |
Friday, June 9, 2023 | ||
时间(协调世界时) (UTC) 12:00 | 国家/地区 US
| 事件 Ocugen Inc Annual Shareholders Meeting Ocugen Inc Annual Shareholders MeetingForecast -Previous - |
Thursday, August 3, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家/地区 US
| 事件 Q2 2023 Ocugen Inc Earnings Release Q2 2023 Ocugen Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
时间(协调世界时) (UTC) 13:30 | 国家/地区 US
| 事件 Q3 2023 Ocugen Inc Earnings Release Q3 2023 Ocugen Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0.04262 | 0 | 0 |
收入 | 0 | 0.04262 | 0 | ||
总营业费用 | 84.868 | 57.628 | 21.3273 | 14.5038 | 28.568 |
销售/一般/行政费用,总计 | 35.111 | 22.92 | 7.97405 | 6.0771 | 10.204 |
研究与开发 | 49.757 | 35.108 | 13.3533 | 8.08552 | 15.634 |
异常费用(收入) | -0.4 | 0 | 0.34114 | 2.73 | |
营业收入 | -84.868 | -57.628 | -21.2847 | -14.5038 | -28.568 |
利息收入(费用),非经营净值 | -0.079 | -0.71989 | -4.95401 | 20.031 | |
其他,净值 | 3.517 | -0.71 | 0.18266 | -0.78487 | -0.106 |
税前净收入 | -81.351 | -58.417 | -21.822 | -20.2426 | -8.643 |
税后净收入 | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
未计算非常项目前的净收益 | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
净收入 | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
Total Adjustments to Net Income | 0 | -12.5463 | 0.121 | ||
普通股股东可获收益 (不含非经常性项目) | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
普通股股东可获收益 (含非經常性項目) | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
摊薄净收入 | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
摊薄后加权平均股 | 214.6 | 195.013 | 112.236 | 13.8938 | 0.60676 |
扣除特别项目的每股摊薄盈利 | -0.37908 | -0.29929 | -0.30621 | -1.45695 | -14.045 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常摊薄盈利 | -0.37908 | -0.30062 | -0.30621 | -1.4324 | -9.54575 |
非常规项目总计 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 17.751 | 24.15 | 23.119 | 19.565 | 18.034 |
销售/一般/行政费用,总计 | 8.193 | 6.937 | 7.497 | 10.558 | 10.119 |
研究与开发 | 9.558 | 17.213 | 15.622 | 9.007 | 7.915 |
营业收入 | -17.751 | -24.15 | -23.119 | -19.565 | -18.034 |
利息收入(费用),非经营净值 | |||||
税前净收入 | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
税后净收入 | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
未计算非常项目前的净收益 | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
净收入 | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
普通股股东可获收益 (不含非经常性项目) | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
普通股股东可获收益 (含非經常性項目) | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
摊薄净收入 | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
摊薄后加权平均股 | 225.524 | 220.133 | 216.591 | 215.863 | 205.693 |
扣除特别项目的每股摊薄盈利 | -0.07316 | -0.09966 | -0.10121 | -0.0902 | -0.0876 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.07316 | -0.09966 | -0.10121 | -0.0902 | -0.0876 |
收入 | |||||
其他,净值 | 1.253 | 2.211 | 1.197 | 0.094 | 0.015 |
Total Adjustments to Net Income | -0.001 | ||||
异常费用(收入) |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 98.492 | 102.646 | 25.8777 | 15.7662 | 16.4 |
现金和短期投资 | 90.934 | 94.958 | 24.0393 | 7.44405 | 15.542 |
现金等价物 | 77.563 | 94.958 | 24.0393 | 7.44405 | 15.542 |
Prepaid Expenses | 7.558 | 2.7 | 1.83836 | 1.32217 | 0.686 |
Total Assets | 108.632 | 105.761 | 27.3764 | 16.8074 | 17.428 |
Property/Plant/Equipment, Total - Net | 9.963 | 2.751 | 1.06662 | 0.22246 | 0.141 |
Intangibles, Net | |||||
Other Long Term Assets, Total | 0.177 | 0.364 | 0.43205 | 0.81876 | 0.887 |
Total Current Liabilities | 18.46 | 7 | 3.61355 | 4.54396 | 2.873 |
Accounts Payable | 8.062 | 2.312 | 0.39503 | 1.89561 | 1.59 |
Accrued Expenses | 10.398 | 4.688 | 2.97464 | 2.44236 | 1 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.23412 | 0 | 0 | |
Other Current Liabilities, Total | 0.00976 | 0.20599 | 0.283 | ||
Total Liabilities | 24.58 | 9.943 | 5.82591 | 5.78904 | 17.886 |
Total Long Term Debt | 2.289 | 1.712 | 1.82304 | 1.07212 | 0 |
Long Term Debt | 2.289 | 1.712 | 1.82304 | 1.07212 | |
Other Liabilities, Total | 3.831 | 1.231 | 0.38932 | 0.17295 | 15.013 |
Total Equity | 84.052 | 95.818 | 21.5504 | 11.0184 | -0.458 |
Common Stock | 2.217 | 1.995 | 1.84133 | 0.52747 | 0.513 |
Additional Paid-In Capital | 294.874 | 225.537 | 93.0587 | 62.0186 | 215.859 |
Retained Earnings (Accumulated Deficit) | -213.018 | -131.667 | -73.3018 | -51.4798 | -216.83 |
Total Liabilities & Shareholders’ Equity | 108.632 | 105.761 | 27.3764 | 16.8074 | 17.428 |
Total Common Shares Outstanding | 221.6 | 199.381 | 184.012 | 52.6252 | 1.03376 |
短期投资 | 13.371 | 0 | |||
Redeemable Preferred Stock | 0.001 | 0.001 | 0 | 0 | |
Other Equity, Total | 0.026 | 0 | |||
Other Current Assets, Total | 4.988 | 0 | 7 | 0.172 | |
Property/Plant/Equipment, Total - Gross | 10.584 | 3.125 | 1.29231 | 10.427 | |
Accumulated Depreciation, Total | -0.621 | -0.374 | -0.2257 | -10.286 | |
Treasury Stock - Common | -0.048 | -0.048 | -0.04786 | -0.04786 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 84.401 | 98.492 | 107.497 | 122.569 | 138.027 |
现金和短期投资 | 76.721 | 90.934 | 101.602 | 115.005 | 129.771 |
现金等价物 | 68.259 | 77.563 | 101.602 | 115.005 | 129.771 |
Prepaid Expenses | 7.68 | 7.558 | 5.895 | 7.564 | 8.256 |
Other Current Assets, Total | |||||
Total Assets | 96.299 | 108.632 | 116.239 | 130.088 | 141.727 |
Property/Plant/Equipment, Total - Net | 7.952 | 9.963 | 8.557 | 7.325 | 3.345 |
Property/Plant/Equipment, Total - Gross | 8.739 | 10.584 | 9.135 | 7.847 | 3.786 |
Accumulated Depreciation, Total | -0.787 | -0.621 | -0.578 | -0.522 | -0.441 |
Other Long Term Assets, Total | 3.946 | 0.177 | 0.185 | 0.194 | 0.355 |
Total Current Liabilities | 15.683 | 18.46 | 14.907 | 10.338 | 7.687 |
Accounts Payable | 8.092 | 8.062 | 6.46 | 5.921 | 3.896 |
Accrued Expenses | 6.335 | 10.398 | 8.447 | 4.417 | 3.791 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.256 | ||||
Total Liabilities | 20.499 | 24.58 | 20.936 | 15.98 | 10.598 |
Total Long Term Debt | 1.058 | 2.289 | 2.265 | 1.75 | 1.731 |
Long Term Debt | 1.058 | 2.289 | 2.265 | 1.75 | 1.731 |
Other Liabilities, Total | 3.758 | 3.831 | 3.764 | 3.892 | 1.18 |
Total Equity | 75.8 | 84.052 | 95.303 | 114.108 | 131.129 |
Common Stock | 2.265 | 2.217 | 2.168 | 2.163 | 2.158 |
Additional Paid-In Capital | 303.073 | 294.874 | 284.231 | 281.139 | 278.704 |
Retained Earnings (Accumulated Deficit) | -229.516 | -213.018 | -191.079 | -169.157 | -149.686 |
Treasury Stock - Common | -0.048 | -0.048 | -0.048 | -0.048 | -0.048 |
Other Equity, Total | 0.025 | 0.026 | 0.03 | 0.01 | |
Total Liabilities & Shareholders’ Equity | 96.299 | 108.632 | 116.239 | 130.088 | 141.727 |
Total Common Shares Outstanding | 226.427 | 221.6 | 216.688 | 216.15 | 215.631 |
Redeemable Preferred Stock | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
短期投资 | 8.462 | 13.371 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
经营活动产生的现金 | -60.079 | -47.941 | -14.7087 | -16.8933 | -15.777 |
经营活动产生的现金 | 0.48 | 0.229 | 0.10211 | 0.06061 | 0.45 |
非现金物品 | 11.597 | 7.757 | 8.2213 | 6.40129 | -14.779 |
Cash Taxes Paid | 0 | 0.052 | 0.105 | ||
已付现金利息 | 0.001 | ||||
营运资金的变化 | 9.195 | 2.438 | -1.21018 | -3.11255 | 7.195 |
投资活动产生的现金 | -16.967 | -1.816 | -0.30683 | -2.35672 | -1.113 |
资本支出 | -4.457 | -1.066 | -0.30683 | -0.02945 | -2.013 |
融资活动产生的现金 | 59.475 | 120.676 | 31.611 | 25.0665 | 25.351 |
融资现金流项目 | -0.592 | -8.525 | -1.48355 | -0.17293 | -0.178 |
股票的发行(报废),净额 | 59.567 | 129.211 | 37.822 | 23.7294 | 25.529 |
现金净变化 | -17.546 | 70.919 | 16.5955 | 5.81646 | 8.461 |
其他投资现金流量项目,总计 | -12.51 | -0.75 | 0 | -2.32727 | 0.9 |
债务的发行(退还),净额 | 0.5 | -0.01 | -4.72744 | 1.51 | |
外汇效应 | 0.025 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.498 | -81.351 | -59.412 | -37.49 | -18.019 |
Cash From Operating Activities | -18.24 | -60.079 | -43.165 | -28.863 | -15.066 |
Cash From Operating Activities | 0.174 | 0.48 | 0.307 | 0.166 | 0.076 |
Non-Cash Items | 3.053 | 11.597 | 7.721 | 5.75 | 3.497 |
Changes in Working Capital | -4.969 | 9.195 | 8.219 | 2.711 | -0.62 |
Cash From Investing Activities | 3.441 | -16.967 | -1.672 | -1.589 | -0.223 |
Capital Expenditures | -1.612 | -4.457 | -2.433 | -1.589 | -0.223 |
Cash From Financing Activities | 5.496 | 59.475 | 51.3 | 50.338 | 50.102 |
Financing Cash Flow Items | -0.235 | -0.592 | -0.398 | -0.248 | -0.075 |
Issuance (Retirement) of Stock, Net | 5.731 | 59.567 | 51.198 | 50.586 | 50.177 |
Issuance (Retirement) of Debt, Net | 0.5 | 0.5 | 0 | 0 | |
Net Change in Cash | -9.304 | -17.546 | 6.493 | 19.896 | 34.813 |
Other Investing Cash Flow Items, Total | 5.053 | -12.51 | 0.761 | 0 | |
Cash Taxes Paid | 0 | 0 | |||
Foreign Exchange Effects | -0.001 | 0.025 | 0.03 | 0.01 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.359 | 13983184 | 325773 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9879 | 13014850 | 1186595 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.3269 | 6071506 | -42605 | 2023-04-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7864 | 4661333 | 517806 | 2023-03-31 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 1.1401 | 2974934 | -38269 | 2023-03-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.9278 | 2420929 | 1982473 | 2023-03-31 | MED |
Renaissance Technologies LLC | Hedge Fund | 0.8744 | 2281548 | 858692 | 2023-03-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.6232 | 1626024 | -54370 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.5821 | 1518828 | -101478 | 2023-03-31 | LOW |
Ergoteles Capital | Hedge Fund | 0.5813 | 1516801 | 1516801 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.4858 | 1267682 | 1267682 | 2023-03-31 | HIGH |
KVM Holdings, L.L.C. | Corporation | 0.4389 | 1145299 | 0 | 2023-04-13 | |
HRT Financial LP | Investment Advisor | 0.3862 | 1007728 | 1007728 | 2023-03-31 | LOW |
Zhang (Junge) | Individual Investor | 0.3698 | 964904 | 0 | 2023-04-13 | |
BNY Mellon Asset Management | Investment Advisor | 0.3315 | 865067 | 25820 | 2023-03-31 | LOW |
Kompella (Uday B.) | Individual Investor | 0.2702 | 705090 | 0 | 2023-04-13 | |
Nuveen LLC | Pension Fund | 0.2576 | 672249 | -483391 | 2023-03-31 | LOW |
BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.23 | 600261 | 15607 | 2023-03-31 | LOW |
Goldman Sachs & Company, Inc. | Research Firm | 0.1887 | 492420 | -900714 | 2023-03-31 | MED |
BofA Global Research (US) | Research Firm | 0.1878 | 490023 | -2389134 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ocugen, Inc. Company profile
关于 Ocugen Inc
Ocugen, Inc.是一家生物制药公司,专注于开发治疗失明疾病的基因疗法和开发COVID-19的疫苗。 公司的技术管线包括。 COVID-19疫苗(0.5),修饰剂基因治疗平台和治疗视网膜疾病的新型生物疗法。 COVID-19候选疫苗的重点是开发、生产和商业化COVAXIN,用于在Ocugen Covaxin地区预防人类的COVID-19。 COVAXIN是一种全病毒灭活的COVID-19候选疫苗,用灭活的SARS-CoV-2病毒配制。 改良剂基因治疗平台旨在治疗视网膜疾病,包括色素性视网膜炎(RP)、利伯氏先天性大脑症(LCA)和干性年龄相关性黄斑变性(AMD)。 该公司正在开发OCU200,一种治疗糖尿病黄斑水肿(DME)、糖尿病视网膜病变(DR)和湿性AMD的生物候选产品。 OCU400是其第一个候选产品,正在用其修饰剂基因治疗平台开发。
Industry: | Biotechnology & Medical Research (NEC) |
11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。